Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

In Vitro Activity of Ertapenem against Neisseria gonorrhoeae Clinical Isolates with Decreased Susceptibility or Resistance to Extended-Spectrum Cephalosporins in Nanjing, China (2013 to 2019)

Antimicrobial Agents and Chemotherapy(2022)10.1128/aac.00109-22Source: DataRank Database

In Vitro Activity of Ertapenem against Neisseria gonorrhoeae Clinical Isolates with Decreased Susceptibility or Resistance to Extended-Spectrum Cephalosporins in Nanjing, China (2013 to 2019) is a research paper published in Antimicrobial Agents and Chemotherapy (2022). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.01)OA: hybridTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Wenjing Le,Xiangdi Lou,Caroline A. Genco ORCID,Peter A. Rice,Xiaohong Su ORCID

Live enrichment

PubMed:35491832 PMC:PMC9112910 OpenAlex:https://openalex.org/W4225279058

CAMS | Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Grant: 2016-I2M-3-021

HHS | National Institutes of Health

Grant: AI084048

HHS | National Institutes of Health

Grant: AI116969

National Institutes of Health

Grant: 5U19AI084048-02

The TLR4/MD-2 signaling pathway in gonoccocal disease

National Institutes of Health

Grant: 1R01AI116969-01A1

Global Transcriptome Analysis of Mucosal Gonoccal Infection

FWCI

2.01

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1128/aac.00109-22

publisherhttps://doi.org/10.1128/aac.00109-22

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.00109-22

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35491832

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9112910

Fields of Study

Reproductive tract infections researchBacterial Infections and VaccinesStreptococcal Infections and Treatments0301 basic medicine03 medical and health sciencesAnti-Bacterial AgentsCeftriaxoneCephalosporinsDrug Resistance, BacterialErtapenemGonorrheaHumansMicrobial Sensitivity TestsNeisseria gonorrhoeae

MeSH Terms

ErtapenemAnti-Bacterial AgentsCeftriaxoneCephalosporinsGonorrheaHumansMicrobial Sensitivity TestsNeisseria gonorrhoeaeDrug Resistance, Bacterial

Keywords

ErtapenemCefiximeNeisseria gonorrhoeaeCephalosporinEtestMicrobiologyCeftriaxoneBiologyAntibioticsMedicineAntibiotic resistanceMeropenemResistanceEscsMicrobial Sensitivity TestsAnti-Bacterial AgentsCephalosporinsGonorrheaSusceptibilityDrug Resistance, BacterialHumans

Sustainable Development Goals

SDG 3: 3. Good health

In Vitro Activity of Ertapenem against Neisseria gonorrhoeae Clinical Isolates with Decreased Susceptibility or Resistance to Extended-Spectrum Cephalosporins in Nanjing, China (2013 to 2019)

FAIR Checklist

Authors (6)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)